Holdings
Spruce Street Capital LP
As of Jun 30, 2026, Spruce Street Capital LP reported 27 positions worth US$410M. Largest: Relay Therapeutics, Inc., Lb Pharmaceuticals Inc and Relmada Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Relay Therapeutics, Inc. | 2.98M | US$55.8M | no change | Jun 30, 2026 |
| Lb Pharmaceuticals Inc | 1.38M | US$44.7M | no change | Jun 30, 2026 |
| Relmada Therapeutics, Inc. | 6.39M | US$44.2M | +129K | Jun 30, 2026 |
| Alto Neuroscience, Inc. | 1.35M | US$35.7M | +27,837 | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 355K | US$34.6M | −18,458 | Jun 30, 2026 |
| Savara, Inc. | 3.45M | US$21.3M | +69,401 | Jun 30, 2026 |
| Vaxcyte, Inc. | 306K | US$17.8M | +60,338 | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 329K | US$16.7M | no change | Jun 30, 2026 |
| Enanta Pharmaceuticals, Inc. | 1.09M | US$15.9M | +156K | Jun 30, 2026 |
| Perspective Therapeutics, Inc. | 3.69M | US$12.6M | +1.07M | Jun 30, 2026 |